z-logo
Premium
Rubinstein–Taybi syndrome predisposing to non‐WNT, non‐SHH, group 3 medulloblastoma
Author(s) -
Bourdeaut Franck,
Miquel Catherine,
Richer Wilfrid,
Grill Jacques,
Zerah Michel,
Grison Camille,
Pierron Gaelle,
Amiel Jeanne,
Krucker Clementine,
Radvanyi Francois,
Brugieres Laurence,
Delattre Olivier
Publication year - 2014
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.24765
Subject(s) - medulloblastoma , medicine , rubinstein–taybi syndrome , pediatrics , dermatology , cancer research
Medulloblastomas (MB) are classified in four subgroups: the well defined WNT and Sonic Hedgehog (SHH) subgroups, and the less defined groups 3 and 4. They occasionally occur in the context of a cancer predisposition syndrome. While germline APC mutations predispose to WNT MB, germline mutations in SUFU , PTCH1 , and TP53 predispose to SHH tumors. We report on a child with a Rubinstein–Taybi syndrome (RTS) due to a germline deletion in CREBBP , who developed a MB. Biological profilings demonstrate that this tumor belongs to the group 3. RTS may therefore be the first predisposition syndrome identified for non‐WNT/non‐SHH MB. Pediatr Blood Cancer 2014;61:383–386. © 2013 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom